IL33 and colitis: Our previous studies showed that IL-33 was markedly increased in the mice with TNBS-induced colitis, while rIL-33 treatment had a significant beneficial effect on Th1/Th17-mediated experimental colitis through promoting alternatively activated macrophage polarization and Tregs differentiation (24, 29).